Direkt zum Inhalt
Merck

Attenuation of lung cancer stem cell tumorigenesis and metastasis by cisplatin.

Experimental lung research (2014-08-26)
Shenxu Wang, Sai Ma, Xiujuan Li, Zengfu Xue, Xiaotian Zhang, Weiwei Fan, Yongzhan Nie, Kaichun Wu, Xiaoyuan Chen, Feng Cao
ZUSAMMENFASSUNG

To investigate the effect of cisplatin on the growth and metastasis abilities of lung cancer stem cells (CSCs) via molecular imaging. The expression changes of lung CSCs cell marker in A549-Luc-C8 human non-small-cell lung cancer (NSCLC) cell line with or without cisplatin treatment were detected by flow cytometry. The tumorigenesis and metastasis abilities of A549-Luc-C8 cells were monitored both in vitro and in vivo, and the mechanism was assessed by gene sequencing. About 1%-2% of CSCs were detected in A549-Luc-C8 cells and decreased CSCs percentage was observed after cisplatin treatment. Attenuated tumorigenesis and metastasis abilities of A549-Luc-C8 cells were found in cisplatin treated group. Decreased percentage of CSCs in A549-Luc-C8 cells can be induced by cisplatin treatment, which may partly be attributed to the attenuated expression of growth factors.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
BIS-TRIS, ≥98.0% (titration)
Sigma-Aldrich
cis-Diamminplatin(II)-dichlorid, crystalline
SAFC
BIS-TRIS
Sigma-Aldrich
BIS-TRIS, BioPerformance Certified, suitable for cell culture, suitable for insect cell culture, ≥98.0%
Sigma-Aldrich
BIS-TRIS, BioXtra, ≥98.0% (titration)
Cisplatin, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
cis-Diaminplatin(II)-dichlorid, ≥99.9% trace metals basis
Sigma-Aldrich
BIS-TRIS, BioUltra, ≥99.0% (NT)
Sigma-Aldrich
trans-Platin(II)diammindichlorid
Cisplatin Unreinheit A, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
FGF-2 human, recombinant, expressed in insect cells, ≥85% (SDS-PAGE)
USP
Transplatin, United States Pharmacopeia (USP) Reference Standard